ArticleClinical kidney journal2022

Vitamin K1 and progression of cardiovascular calcifications in hemodialysis patients: the VitaVasK randomized controlled trial.

Turgay Saritas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.